Expression of galectin-1 and galectin-3 in tumor cells can block apoptosis; when shed in the tumor microenvironment, both galectins induce T cell apoptosis via CD45 and CD7 binding on T cell surface, favoring, indeed, tumor immune escape [17]. Here, PTPRC is linked to neoplasm.